Navigation Links
Dialysis Corporation of America Announces Fiscal Year 2007 Earnings Release Date
Date:2/29/2008

LINTHICUM, Md., Feb. 29 /PRNewswire-FirstCall/ -- Dialysis Corporation of America (Nasdaq: DCAI) announced today that it will release its 2007 fourth quarter and full year financial results on March 13, 2008, after the close of the market. The company will also begin hosting conference calls in conjunction with its quarterly earnings releases, beginning with this quarter. The conference call will he held the following morning, March 14, 2008 at 10:00 AM EDT.

Those interested may dial in at 800-750-4984 using passcode 5178437, or through simulcast on the internet at http://www.vcall.com/IC/CEPage.asp?ID=126643. The call will be available for replay on the company's website for the following thirty days.

Separately, the company announced the appointment of Andrew Jeanneret as the company's Chief Financial Officer, effective with the filing of the 2007 10K. Mr. Jeanneret, who has been serving the company as Vice President of Finance since August of 2007, will be replacing Dan Ouzts, who has been serving as the interim CFO since late 2005. Mr. Ouzts will continue to provide financial, treasury, and SEC guidance for DCA, through the DCA regional offices in Florida.

Stephen Everett, President and Chief Executive Officer commented, "The combined finance team of Andrew and Dan will provide our company with a higher level of financial insight into the growth and strategic plans for DCA. I look forward to working with Andrew in his new role and the continued relationship that has been enjoyed with Dan over the years."

This release contains forward-looking statements that are subject to risks and uncertainties that could affect the business and prospects of the company and cause actual results and plans to differ materially from those anticipated. Those factors include, but are not limited to, maintaining continued growth and profitability, delays beyond the company's control with respect to future business events, the highly competitive environment in the establishment and operation of dialysis centers, the ability to develop or acquire additional dialysis facilities, whether patient bases of the company's dialysis facilities can mature to provide profitability, the extensive regulation of dialysis operations, government rate determination for Medicare reimbursement, pricing pressure from private payors, and other risks detailed in the company's filings with the SEC, particularly as described in the company's annual report on Form 10-K for the fiscal year ended December 31, 2006. The historical results contained in this press release are not necessarily indicative of future performance of the company.

The company's press releases, corporate profile, corporate governance materials, quarterly and current reports, and other filings with the SEC are available on Dialysis Corporation of America's internet home page: http://www.dialysiscorporation.com.


'/>"/>
SOURCE Dialysis Corporation of America
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Dialysis Corporation of America Announces its Newest Center Opening in South Carolina
2. Standard test for blood sugar control not accurate in diabetic dialysis patients
3. Dialysis Corporation of America Announces Opening of New Dialysis Center in Ohio
4. Nations Leading Dialysis Provider - DaVita - Partners with eDiets(R) to Launch One-of-a-Kind Diet Helper Online Nutrition and Meal Planning Tool for Late-Stage Kidney Disease Patients and Caregivers
5. 16-Year-Old Ecuadorian Boy in Dire Need of Dialysis Treatments Thanks One of Nations Leading Providers for Saving His Life
6. Study questions impact of hemoglobin variations on mortality in dialysis patients
7. New anemia measure predicts risk of death in dialysis patients
8. Home Dialysis Clinical Research Study is Underway - Focuses on At-Home Extended Duration Treatment
9. DaVita to Open First Independent Dialysis Clinic in Fargo-Moorhead
10. DaVita Emergency Response Efforts Ensure Vital Treatment for More than 700 Kidney Failure Patients in Need of Life-Saving Dialysis Treatments in Areas Affected by Southern California Wildfires
11. Renal Solutions, Inc. Announces FDA 510(k) Clearance of New Design of the Allient(R) Sorbent Hemodialysis System for Chronic and Acute Hemodialysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: